Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
作者： B. B. Samura , M. O. Panasenko
DOI: 10.14739/2409-2932.2020.1.198217
关键词: Chemotherapy 、 Multiple myeloma 、 Internal medicine 、 Cardiology 、 Radiation therapy 、 Cardiotoxicity 、 Heart failure 、 Drug 、 Medicine 、 Pericarditis 、 Monoclonal antibody
摘要: Heart dysfunction that occurred after using cytostatic drugs and monoclonal antibodies may be a limit factor in the treatment of multiple myeloma. Side effects chemotherapy include hypotension, hypertension, arrhythmias, conduction disturbances, pericarditis, thromboembolic events, heart failure, death.The risk cardiotoxicity increased by some factors drug exposure, age, history diseases, arterial combination, previous radiotherapy or chemotherapy. It’s important to detect cardiovascular toxicity before appearance clinical signs vessel disturbance. The role markers elicitation groups events is uncertain yet.Early diagnostics definition prognostic appeared polychemotherapy oncohematological diseases are not solve problems. multiple myeloma, chemotherapy, diagnostics, factors.
sci-hub.st 参考文章(38)
Anna Lipińska, Anna Krześlak, Galectin-3 as a multifunctional protein. Cellular & Molecular Biology Letters. ,vol. 9, pp. 305- 328 ,(2004)
Daniela Cardinale, Alessandro Colombo, Giuseppina Lamantia, Nicola Colombo, Maurizio Civelli, Gaia De Giacomi, Mara Rubino, Fabrizio Veglia, Cesare Fiorentini, Carlo M. Cipolla, Anthracycline-Induced Cardiomyopathy: Clinical Relevance and Response to Pharmacologic Therapy Journal of the American College of Cardiology. ,vol. 55, pp. 213- 220 ,(2010) , 10.1016/J.JACC.2009.03.095
Lorena Maries, Ioan Manitiu, Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP) Cardiovascular Journal of Africa. ,vol. 24, pp. 286- 289 ,(2013) , 10.5830/CVJA-2013-055
Murat Soker, Mehmet Kervancioglu, Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Medical Journal. ,vol. 26, pp. 1197- 1202 ,(2005)
Romolo M Dorizzi, Marco Caputo, Anna Ferrari, Lorella Lippa, Paolo Rizzotti, Comparison of Serum and Heparin-Plasma Samples in Different Generations of Dimension Troponin I Assay Clinical Chemistry. ,vol. 48, pp. 2294- 2296 ,(2002) , 10.1093/CLINCHEM/48.12.2294
Barry Kevane, Maeve P. Crowley, Margaret Bolster, Oonagh Gilligan, Myeloma Relapse Involving the Heart and Presenting As Acute Cardiac Failure Journal of Clinical Oncology. ,vol. 32, ,(2014) , 10.1200/JCO.2012.47.6713
Giorgina Specchia, Caterina Buquicchio, Nicola Pansini, Francesca Di Serio, Vincenzo Liso, Domenico Pastore, Giuseppina Greco, Lucia Ciuffreda, Anna Mestice, Arcangelo Liso, Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines Journal of Laboratory and Clinical Medicine. ,vol. 145, pp. 212- 220 ,(2005) , 10.1016/J.LAB.2005.02.003
Tommaso Za, Elena Rossi, Valerio Stefano, Venous thromboembolism in multiple myeloma. Seminars in Thrombosis and Hemostasis. ,vol. 40, pp. 338- 347 ,(2014) , 10.1055/S-0034-1370793
Katie Bentley, Claudio Areias Franco, Andrew Philippides, Raquel Blanco, Martina Dierkes, Véronique Gebala, Fabio Stanchi, Martin Jones, Irene M. Aspalter, Guiseppe Cagna, Simone Weström, Lena Claesson-Welsh, Dietmar Vestweber, Holger Gerhardt, The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis Nature Cell Biology. ,vol. 16, pp. 309- 321 ,(2014) , 10.1038/NCB2926
Jens Vogel-Claussen, J. Paul Finn, Antoinette S. Gomes, Gregory W. Hundley, Michael Jerosch-Herold, Gregory Pearson, Shantanu Sinha, Jo??o A.C. Lima, David A. Bluemke, Left ventricular papillary muscle mass: relationship to left ventricular mass and volumes by magnetic resonance imaging. Journal of Computer Assisted Tomography. ,vol. 30, pp. 426- 432 ,(2006) , 10.1097/00004728-200605000-00013